Basel, Switzerland, March 2026 — Danielle Hartmann has taken on a new leadership mandate at Roche, leading the new Inclusion & Belonging International organization as Head of Inclusion & Belonging International. She steps into the role after serving as Global Head of Equity Strategy, continuing her progression within the company’s global inclusion, equity and belonging agenda.
In her journey at Roche, Danielle Hartmann has been with the organization for over a decade. Prior to her current appointment (March 2026), she served as Global Head of Equity Strategy (October 2024 to March 2026) and earlier as Global Diversity & Inclusion Partner (June 2021 to October 2024), contributing to strategy development and enterprise-wide implementation across inclusion and equity priorities.
Before joining Roche, she spent significant years with Boston College, Center for Work & Family, serving as Director of Corporate Partnerships, where she managed corporate relations and programming and worked consultatively with multinational organizations on global workforce strategies, workplace flexibility, diversity & inclusion, cross-cultural communications and wellness initiatives. She earlier served as Asst. Director, Global Workforce Roundtable, where she increased global corporate partnerships and led initiatives including summits and publications on global workforce topics.
Earlier in her career, Danielle Hartmann worked with the University of Wisconsin–Madison as Assistant Director, BASIS CRSP, managing administration for a multi-year agreement focused on poverty alleviation across multiple regions, and held early roles including HR Assistant at TDS Telecom and Program Coordinator at ESI International.
About Roche
Roche is a global company in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The company combines pharmaceuticals and diagnostics under one roof and describes its strategy as personalised healthcare, aiming to fit the right treatment to each patient. Roche develops medicines across areas including oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system, and is also active in in vitro diagnostics and tissue-based cancer diagnostics. Founded in 1896, Roche states it works to prevent, diagnose and treat diseases and improve access to medical innovations, and has been recognised for sustainability leadership in its industry.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
Click Here to Join HR TODAY WhatsApp Channel
